A randomized comparison of triptorelin and tamoxifen as treatment of progressive ovarian cancer

W. Jager, W. Sauerbrei, E. Beck, V. Maassen, M. Stumpfe, W. Meier, W. Kuhn, F. Janicke

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Abstract

This randomized study gives evidence that a reduction of gonadotrophins by GnRH-analogues do not substantially improve the outcome of progressive ovarian cancer.

Original languageEnglish
Pages (from-to)2639-2642
Number of pages4
JournalAnticancer Research
Volume15
Issue number6 B
StatePublished - 1995
Externally publishedYes

Keywords

  • GnRh-analogues
  • Ovarian cancer
  • Tamoxifen

Fingerprint

Dive into the research topics of 'A randomized comparison of triptorelin and tamoxifen as treatment of progressive ovarian cancer'. Together they form a unique fingerprint.

Cite this